$0.46
9.44% yesterday
Nasdaq, Jun 27, 10:15 pm CET
ISIN
US4169061052
Symbol
HBIO
Sector
Industry

Harvard Bioscience, Inc. Stock price

$0.46
+0.09 24.19% 1M
-1.52 76.59% 6M
-1.65 78.03% YTD
-2.44 84.01% 1Y
-3.31 87.70% 3Y
-2.66 85.14% 5Y
-5.20 91.81% 10Y
-1.95 80.82% 20Y
Nasdaq, Closing price Fri, Jun 27 2025
-0.05 9.44%
ISIN
US4169061052
Symbol
HBIO
Sector
Industry

Key metrics

Basic
Market capitalization
$20.5m
Enterprise Value
$50.9m
Net debt
$30.4m
Cash
$5.6m
Shares outstanding
44.2m
Valuation (TTM | estimate)
P/E
negative | 9.09
P/S
0.22 | 0.23
EV/Sales
0.56 | 0.57
EV/FCF
negative
P/B
1.38
Financial Health
Equity Ratio
50.01%
Return on Equity
-19.58%
ROCE
-19.69%
ROIC
-7.39%
Debt/Equity
2.42
Financials (TTM | estimate)
Revenue
$91.4m | $88.9m
EBITDA
$320.0k | $7.4m
EBIT
$-4.8m
Net Income
$-58.1m | $2.3m
Free Cash Flow
$-200.0k
Growth (TTM | estimate)
Revenue
-14.41% | -5.57%
EBITDA
-90.42% | 6,262.50%
EBIT
-123.98%
Net Income
-564.95% | 118.13%
Free Cash Flow
-101.85%
Margin (TTM | estimate)
Gross
57.09%
EBITDA
0.35% | 8.32%
EBIT
-5.21%
Net
-63.52% | 2.54%
Free Cash Flow
-0.22%
More
EPS
$-1.32
FCF per Share
$0.00
Short interest
6.93%
Employees
343.00
Rev per Employee
$270.00k
Show more

Is Harvard Bioscience, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Harvard Bioscience, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Harvard Bioscience, Inc. forecast:

6x Buy
75%
2x Hold
25%

Analyst Opinions

8 Analysts have issued a Harvard Bioscience, Inc. forecast:

Buy
75%
Hold
25%

Financial data from Harvard Bioscience, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
91 91
14% 14%
100%
- Direct Costs 39 39
11% 11%
43%
52 52
17% 17%
57%
- Selling and Administrative Expenses 42 42
10% 10%
46%
- Research and Development Expense 9.84 9.84
16% 16%
11%
0.32 0.32
90% 90%
0%
- Depreciation and Amortization 5.08 5.08
7% 7%
6%
EBIT (Operating Income) EBIT -4.76 -4.76
124% 124%
-5%
Net Profit -58 -58
565% 565%
-64%

In millions USD.

Don't miss a Thing! We will send you all news about Harvard Bioscience, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Harvard Bioscience, Inc. Stock News

Neutral
GlobeNewsWire
26 days ago
HOLLISTON, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the appointment of John Duke to its board of directors, effective June 2, 2025. Mr. Duke will also serve on the audit and nominating and governance committees. The Company also announced that Katherine Eade has been named Lead Independent Director of the Company's board of...
Neutral
Seeking Alpha
about 2 months ago
Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q1 2025 Earnings Conference Call May 12, 2025 8:00 AM ET Company Participants Kathryn Flynn - Corporate Controller Jim Green - Chairman, President & CEO Mark Frost - Interim CFO Conference Call Participants Paul Knight - KeyBanc Bruce Jackson - The Benchmark Company Operator Good day, and welcome to the First Quarter 2025 Harvard Bioscience Inc Earnings C...
Neutral
GlobeNewsWire
about 2 months ago
HOLLISTON, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the first quarter ended March 31, 2025.
More Harvard Bioscience, Inc. News

Company Profile

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

Head office United States
CEO James Green
Employees 343
Founded 1901
Website www.harvardbioscience.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today